Health & Environmental Research Online (HERO)


Print Feedback Export to File
7370864 
Journal Article 
On the practical aspects of large-scale production of Lu-177 for peptide receptor radionuclide therapy using direct neutron activation of Lu-176 in a medium flux research reactor: the Indian experience 
Chakraborty, S; Vimalnath, KV; Lohar, SP; Shetty, P; Dash, A 
2014 
Yes 
Journal of Radioanalytical and Nuclear Chemistry
ISSN: 0236-5731
EISSN: 1588-2780 
302 
1 
233-243 
WOS:000342134800028 
This paper accentuates on the practical aspects and intricate technicalities involved in the large-scale production of 177Lu with specific activity >740 GBq mg−1 following (n,γ)177Lu route in a medium flux (~1.2 × 1014 n cm−2 s−1 thermal neutron) research reactor. The implication of target burn-up on the specific activity of 177Lu during irradiation was discussed in detail. 177Lu obtained from this route has been extensively utilized for targeted therapy in patients with neuroendocrine tumor in India. The important details available from our experience, as well as technical know-how, would be of considerable value for institutions planning to pursue 177Lu production through (n,γ)177Lu route. 
Targeted radionuclide therapy; (n,gamma)Lu-177; Target burn-up; Specific activity